Type 2 Diabetic Dyslipidemia: A Review

Authors

  • Gyanendra kumar Gupta Professor and Head of Department, Department of Kriya Sharir, SRS Ayurvedic Medical College, Agra, Uttar Pradesh, India
  • Gagan Devi Assistant Professor, Department of Rachna Sharir, SRS Ayurvedic Medical College, Agra, Uttar Pradesh, India

DOI:

https://doi.org/10.37591/rrjomst.v10i2.2606

Keywords:

diabetes mellitus, diabetic dyslipidemia, lipoproteins, pathological, insulin

Abstract

Diabetic dyslipidemia is a pathological condition where persistent rise in blood glucose level gives rise to derangement of lipids vis-a vis lipoproteins; which in turn increases the risk of cardiovascular diseases. Although both forms of diabetes mellitus that is, Diabetes mellitus Type-1 (insulin-dependent diabetes mellitus or IDDM) and Diabetes mellitus Type-2 (non-insulin-dependent diabetes mellitus or NIDDM) can alter lipid arrangement but Type-2 is more common (80–90%) form of diabetes mellitus, better controlled by indigenous drugs and insulin resistance is important underlying cause whereas Type-1 is less common (10–20%) form, cannot be controlled by indigenous drugs alone and genetic defect is important underlying cause. The topic chosen in the present study was Type-2 diabetic dyslipidemia.

References

Edwards CRW (Eds.). Davidson's Principles and Practice of Medicine, 17th Edn. UK: Churchill Livingstone; 1995.

Boloor A, Nayak R. Exam Preparatory Manual for Undergraduates Medicine, 2nd Edn. New Delhi, India: Jaypee Brothers Medical Publishers; 2018.

Mathew KG, Aggarwal P. Manual for undergraduates Medicine, 2nd Edn. New Delhi, India: Elsevier; 2006. 883–885p.

Mohan H. Textbook of Pathology, 4th Edn. New Delhi: Jaypee Brothers Medical Publishers (Pvt.) Ltd.; 2002. 803p.

Braunwald F, Kasper H, Longo J. Harrison’s principles of internal medicine, Vol 2, 15th Edn. New York: McGraw-Hill Medical Publishing Division; 2001. 2116–2118p.

Munjal YP. API text book of medicine, Vol 1, 9th Edn. New Delhi: Jaypee Brother’s Medical Publishers (Pvt.) Ltd.; 2012. 362p, 370p, 385p.

Chehade JM, et al. Dyslipidemia in type 2 diabetes: Prevalence, pathophysiology, and management. Drugs. 2013; 73(4): 327–339p.

Goldberg IJ. Diabetic Dyslipidemia: Causes and Consequences. The Journal of Clinical Endocrinology & Metabolism. 2001; 86(3): 965–971p.

Duff G, MacMillan G. The effect of alloxan diabetes on experimental atherosclerosis in the rabbit. J Exp Med. 1949; 89: 611–630p.

Steiner G. Lipid intervention trials in diabetes. Diabetes Care. 2000; 23 (Suppl 2): B49–B53.

Downloads

Published

2021-10-08

Issue

Vol. 10 No. 2 (2021)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.